Titan Pharmaceuticals, Inc. Debt Conversion, Original Debt, Amount
Titan Pharmaceuticals, Inc. reported Debt Conversion, Original Debt, Amount of $0 for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2020-11-16
- Titan Pharmaceuticals, Inc. debt conversion, original debt, amount for the quarter ending 2020-09-30 was $0.00.
- Titan Pharmaceuticals, Inc. debt conversion, original debt, amount for the quarter ending 2019-09-30 was $0.00.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month |
|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-14 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $650.00K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $650.00K 10-Q · filed 2020-08-14 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-14 |